KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) EPS (Weighted Average and Diluted) (2019 - 2025)

Guardant Health (GH) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with -$1.0 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 11.11% to -$1.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.31 through Dec 2025, up 7.02% year-over-year, with the annual reading at -$3.32 for FY2025, 6.74% up from the prior year.
  • EPS (Weighted Average and Diluted) hit -$1.0 in Q4 2025 for Guardant Health, down from -$0.74 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.67 in Q2 2023 to a low of -$2.25 in Q2 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$1.08 across 5 years, with a median of -$0.95 in 2021.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 134.38% in 2022 and later skyrocketed 70.22% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.89 in 2021, then crashed by 53.93% to -$1.37 in 2022, then dropped by 18.25% to -$1.62 in 2023, then soared by 44.44% to -$0.9 in 2024, then decreased by 11.11% to -$1.0 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for GH at -$1.0 in Q4 2025, -$0.74 in Q3 2025, and -$0.8 in Q2 2025.